JAKARTA, KOMPAS.com – Indonesia’s Food and Drug Monitoring Agency (BPOM) has issued emergency use authorization to AstraZeneca’s Covid-19 vaccine produced by UK pharmaceutical firm.
“BPOM granted emergency use authorization [EUA] to AstraZeneca’s Covid-19 vaccine on February 22 under the EUA number 2158100143A1,” BPOM head Penny Lukito told a press conference which was held virtually on Tuesday, March 9.
Penny said that the application for the emergency use of the Covid-19 vaccine was done multilaterally and registered directly by AstraZeneca Indonesia.
"It was registered through the bilateral production line of AstraZeneca in Europe and Siam Bioscience in Thailand," she said.
She said before granting the emergency use permit, BPOM had evaluated with the National Committee for Drug Evaluation and other relevant parties.
Terima kasih telah membaca Kompas.com.
Dapatkan informasi, inspirasi dan insight di email kamu.
She further added that they had estimated the efficacy of the vaccine was 62.1 percent.
Indonesia received the first shipment of more than a million doses of AstraZeneca’s Covid-19 vaccine on Monday, March 8.
Foreign Minister Retno Marsudi said it was the first batch of vaccines that Indonesia received through the multilateral channel. During the first phase, which runs until May, Indonesia will receive a total of 11,748,000 ready-to-use vaccines.
"Insya Allah [God willing], next batches will follow suit,” she said.
(Writer: Haryanti Puspa Sari | Editor: Kristian Erdianto)